Mavyret Cost 2025: Real Prices & How to Save More

Honestly, seeing a price tag like “$13,200 per month” can feel like a punch to the gut. You’re not alone—many people wonder if they’ll ever afford the medication that could finally clear hepatitis C from their bodies. The good news? The list price is just one piece of the puzzle. Insurance, savings cards, and patient‑assistance programs can shrink that number dramatically. Below is a friendly, step‑by‑step walk‑through of what you’ll actually pay for Mavyret in 2025 and every legit way to keep the bill under control.

Quick Pricing Snapshot

Scenario	Approx. Monthly Cost	Full‑Course Cost	Key Note
Wholesale Acquisition Cost (WAC)	$13,200 / month (Jan 2024)	$13,200 × treatment length*	Official list price; rarely what patients pay.
Cash price (84 tablets)	$13,909 (Drugs.com, 2025)	—	Varies by pharmacy; no insurance.
Medicaid	≤ $20 / month (state‑dependent)	—	96 % preferred/exclusive coverage*.
Commercial insurance + Savings Card	$5 – $12 / month	—	Maximum lifetime benefit $12,000.
Medicare Part D	$0 – $3,300 / month (donut‑hole)	—	Low‑Income Subsidy = $11.20 / month.
Uninsured / Patient‑Assistance	$0 – $2,000 / month	—	Via AbbVie’s myAbbVie Assist program.

*Typical 8‑week regimen (84 tablets) for all HCV genotypes without cirrhosis; a 12‑week course adds an extra month.

Insurance Impact

What “specialty medication” really means

When your pharmacy label says “specialty,” it’s not a comment on the drug’s quality—it simply flags that the medication requires special handling, often a higher copay tier, and a prior‑authorization from your insurer. That’s why many patients see a “specialty” tag on their Mavyret claim.

Medicaid vs. Medicare vs. Commercial plans

AbbVie reports that 96 % of Medicaid plans list Mavyret as a preferred or exclusive option, while 82 % of commercial formularies do the same. According to AbbVie’s coverage data, this means the drug is often placed on the “preferred” tier, which dramatically reduces out‑of‑pocket costs. Medicare beneficiaries, however, may hit the infamous “donut hole,” where they pay a larger share until they reach the catastrophic phase.

When does the donut hole hit?

Think of Medicare Part D as a three‑stage roller coaster. You start with a deductible (often $0‑$445), then pay a copay or coinsurance (about 25 %). Once you’ve spent roughly $4,500 in total drug costs, you enter the coverage gap—the “donut hole.” Here, you’re on the hook for 25 % of the drug’s price until you reach the catastrophic threshold (around $7,000). After that, the plan kicks back in and you pay only 5 %.

Example: Two patients, two outcomes

Patient A has commercial insurance with a $500 deductible and qualifies for the Mavyret Savings Card. After the deductible, the card caps her cost at $5 per month. Patient B is on Medicare Part D without low‑income subsidies; after the deductible, she pays $2,500 before hitting the donut hole, then $2,500 again in the gap, ending up with a bill close to $5,000 for the full course. The difference is stark, but both patients can still seek assistance.

Savings Programs

MAVYRET Savings Card

If you have private or commercial insurance, you may qualify for AbbVie’s free Savings Card. It reduces your out‑of‑pocket cost to as low as $5 per month, and the benefit caps at $12,000 over a lifetime. To get it, simply download the PDF from the official site, fill out the short form, and fax or upload it to your pharmacy.

AbbVie Patient‑Assistance (myAbbVie Assist)

No insurance? No problem. The myAbbVie Assist program helps qualifying patients—those with low income, uninsured, or underinsured—obtain Mavyret at a heavily reduced price or sometimes for free. You’ll need proof of income, a prescription, and a brief medical history. Call 1‑800‑222‑6885 or visit the program’s website to start the application.

Third‑party discount cards

• GoodRx – prints coupons that can shave up to 80 % off cash price (no insurance required).
• SingleCare – lists an average price of $16,660 for 84 tablets, but its coupons bring that down to about $12,848 (according to SingleCare).

State formulary lookup

AbbVie’s formulary lookup tool lets you pick your state and see whether Mavyret is on a preferred tier, exclusive, or needs a medical exception. Knowing this before you call your pharmacy can save you hours of back‑and‑forth.

Step‑by‑step checklist before you call

1. Gather your prescription (glide‑copy OK).
2. Have your insurance card handy (including member ID).
3. Print or download the Savings Card PDF.
4. Write down the phone number 1‑877‑628‑9738 for AbbVie’s assistance line.
5. Ask the pharmacy if they can apply the discount before you leave the store.

No Generic Yet

Current regulatory status

As of 2025, Mavyret remains a brand‑only drug. The FDA’s Orange Book confirms that no generic version of glecaprevir/pibrentasvir is approved yet. This exclusivity is a major driver of the high list price.

Impact on price elasticity

When a medication has no competition, manufacturers can set a premium price, knowing patients and providers have limited alternatives. That’s why the WAC sits above $13,000 per month. However, the presence of multiple insurance programs and assistance cards helps blunt that impact for most patients.

Future outlook

Patents on glecaprevir and pibrentasvir are expected to expire in the early 2030s. Keep an eye on news from the FDA and major generic manufacturers—once a generic hits the market, we can anticipate a 30‑60 % price drop.

Treatment Length Costs

Standard 8‑week regimen (genotypes 1‑6, no cirrhosis)

84 tablets are taken once daily for eight weeks. Using the Savings Card, out‑of‑pocket costs can be as low as $5 per month, meaning you’ll pay under $40 total for the entire cure.

Extended 12‑week regimen (compensated cirrhosis)

Patients with compensated cirrhosis take the same 84 tablets but over a 12‑week period, adding an extra month of cost. With the Savings Card, that’s still roughly $15 total.

Real‑world case study

James, a 52‑year‑old living in Ohio, was on Medicaid. He paid $18 total for his 8‑week course after the state’s $20‑per‑month cap applied. He told his nurse, “I thought I’d be broke, but it was actually cheaper than my monthly coffee habit.”

Talk With Your Provider

Bring the cost table to the appointment

Print the Quick Pricing Snapshot table above and hand it to your doctor. It shows you’ve done homework and signals that you’re serious about affordability.

Ask about “split‑fill” options

Some pharmacies will let you pick up a half‑dose now and the rest later, giving you time to secure a coupon or insurance approval.

Sample script

“Doctor, I saw that the list price for Mavyret is over $13,000, but I qualify for the $5‑a‑month savings card. Could we submit the paperwork together so I don’t end up with a surprise bill?”

Real Experiences (Empathy & Trust)

Patient story: Medicaid miracle

Maria, a single mother from Texas, was terrified when she learned she needed Mavyret. After contacting her state Medicaid office, she discovered her plan covered the drug for $15 total. “I could finally focus on caring for my kids instead of worrying about money,” she shares.

Clinician perspective

Dr. Patel, a hepatology specialist, explains: “Even though the headline price looks scary, we have tools—savings cards, assistance programs—that bring the cost down for most of my patients. The cure is worth navigating the paperwork.”

Curious about how Mavyret stacks up against other cures? Check out our Mavyret vs Epclusa comparison for a side‑by‑side look.

Long‑Term Safety & What to Avoid

Cost is only one piece of the puzzle; you also want to know what the medication does to your body over time. For a deep dive into long‑term safety, read our article on long‑term side effects of Mavyret. And if you’re wondering what to avoid when taking Mavyret, we’ve got a handy list of food, drink, and drug interactions.

Stopping Mavyret can bring its own set of questions. Our piece on Mavyret side effects after stopping explains what to watch for and when to call your doctor.

Key Takeaways

• The wholesale price is > $13,000/month, but most patients pay far less.
• Medicaid, the Savings Card, and AbbVie’s patient‑assistance program can reduce out‑of‑pocket costs to under $20 total.
• Medicare beneficiaries should watch for the coverage gap; low‑income subsidies can bring the bill down to $11.20/month.
• No generic exists yet, but the market is likely to change in the next decade.
• Speak openly with your prescriber, bring the pricing table, and ask about savings tools before signing a prescription.

Feeling a little less overwhelmed? Great! Remember, the price tag you see on the website isn’t the final amount you’ll pay—there’s a whole toolbox of savings waiting for you. If you’ve already navigated the process, share your tip with a friend who’s just starting out. And if you’re still unsure, don’t hesitate to call AbbVie’s assistance line or your pharmacist. Together, we can make sure the cure doesn’t break the bank.